| Origin and evolution of pathogenic coronaviruses |
982 |
| The microbial nitrogen-cycling network |
260 |
| Cyanobacterial blooms |
221 |
| Implant infections: adhesion, biofilm formation and immune evasion |
188 |
| Best practices for analysing microbiomes |
172 |
| The human skin microbiome |
156 |
| The oral microbiota: dynamic communities and host interactions |
142 |
| Keystone taxa as drivers of microbiome structure and functioning |
130 |
| Bacteria and archaea on Earth and their abundance in biofilms |
129 |
| Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research |
113 |
| Electroactive microorganisms in bioelectrochemical systems |
112 |
| Scientists' warning to humanity: microorganisms and climate change |
109 |
| Definitions and guidelines for research on antibiotic persistence |
108 |
| Fungal secondary metabolism: regulation, function and drug discovery |
106 |
| Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis |
104 |
| Culturing the human microbiota and culturomics' |
91 |
| Drug combinations: a strategy to extend the life of antibiotics in the 21 st century |
91 |
| Uncovering the mechanisms of Acinetobacter baumannii virulence |
90 |
| Types and origins of bacterial membrane vesicles |
87 |
| Autophagy during viral infection - a double-edged sword |
86 |
| Mycobiome diversity: high-throughput sequencing and identification of fungi |
81 |
| Multidrug efflux pumps: structure, function and regulation |
78 |
| Streptococcus pneumoniae: transmission, colonization and invasion |
77 |
| Interplay between beta-lactamases and new beta-lactamase inhibitors |
71 |
| Fusobacterium nucleatum - symbiont, opportunist and oncobacterium |
70 |
| Bacterial quorum sensing in complex and dynamically changing environments |
67 |
| Diet-microbiota interactions and personalized nutrition |
64 |
| Development and regulation of single- and multi-species Candida albicans biofilms |
63 |
| Microbial modulation of cardiovascular disease |
57 |
| Ecology and evolution of Mycobacterium tuberculosis |
54 |
| Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier |
54 |
| Host and viral determinants of influenza A virus species specificity |
52 |
| ISG15 in antiviral immunity and beyond |
51 |
| Controlling vector-borne diseases by releasing modified mosquitoes |
51 |
| The evolution of seasonal influenza viruses |
51 |
| Functional horizontal gene transfer from bacteria to eukaryotes |
50 |
| Bacterial adhesion at the single-cell level |
50 |
| Anti-CRISPR: discovery, mechanism and function |
50 |
| Pseudomonas syringae: what it takes to be a pathogen |
50 |
| Rhizobia: from saprophytes to endosymbionts |
50 |
| Pushing the envelope: LPS modifications and their consequences |
46 |
| Microbial genes and pathways in inflammatory bowel disease |
45 |
| An evolving view of methane metabolism in the Archaea |
44 |
| Drug resistance in Plasmodium |
44 |
| Developmental roadmap for antimicrobial susceptibility testing systems |
44 |
| Bacterial microcompartments |
43 |
| Biosynthetic capacity, metabolic variety and unusual biology in the CPR and DPANN radiations |
42 |
| Rewiring cellular networks by members of the Flaviviridae family |
42 |
| Why does the microbiome affect behaviour? |
40 |
| Targeting mechanisms of tailed bacteriophages |
40 |
| The life cycle of non-polio enteroviruses and how to target it |
37 |
| Mechanisms and clinical relevance of bacterial heteroresistance |
36 |
| Engineering bacteria for diagnostic and therapeutic applications |
35 |
| RNA-binding proteins in bacteria |
35 |
| Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues |
33 |
| The ancestral and industrialized gut microbiota and implications for human health |
33 |
| The social network of microorganisms - how auxotrophies shape complex communities |
32 |
| CRISPR-Cas in mobile genetic elements: counter-defence and beyond |
31 |
| Molecular mechanisms of CRISPR-Cas spacer acquisition |
31 |
| Fungi in aquatic ecosystems |
31 |
| Coral microbiome dynamics, functions and design in a changing world |
29 |
| Therapeutic strategies to target the Ebola virus life cycle |
29 |
| Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection |
29 |
| Campylobacter jejuni: collective components promoting a successful enteric lifestyle |
28 |
| The spread and evolution of rabies virus: conquering new frontiers |
27 |
| Evolution and ecology of plant viruses |
27 |
| Structural insights into the signalling mechanisms of two-component systems |
26 |
| The role of microbial motility and chemotaxis in symbiosis |
26 |
| Biofilm-associated infection by enterococci |
25 |
| Origins and evolutionary consequences of ancient endogenous retroviruses |
25 |
| Type IV pili: dynamics, biophysics and functional consequences |
24 |
| Neisseria gonorrhoeae host adaptation and pathogenesis |
24 |
| The birth, evolution and death of metabolic gene clusters in fungi |
23 |
| Origin of viruses: primordial replicators recruiting capsids from hosts |
23 |
| The germ-organ theory of non-communicable diseases |
22 |
| The microbiomes of deep-sea hydrothermal vents: distributed globally, shaped locally |
22 |
| Glycointeractions in bacterial pathogenesis |
21 |
| Hopanoid lipids: from membranes to plant-bacteria interactions |
21 |
| Microbiology of the built environment |
21 |
| Prokaryotic cytoskeletons: protein filaments organizing small cells |
21 |
| Common principles and best practices for engineering microbiomes |
21 |
| Simple animal models for microbiome research |
21 |
| Protein post-translational modifications in bacteria |
21 |
| Protozoan persister-like cells and drug treatment failure |
20 |
| Ecology and evolution of seafloor and subseafloor microbial communities |
20 |
| Synthetic ecology of the human gut microbiota |
19 |
| Envelope stress responses: balancing damage repair and toxicity |
18 |
| Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis |
18 |
| Light sensing and responses in fungi |
18 |
| Molecular mechanisms of viral oncogenesis in humans |
18 |
| Latency and lytic replication in Epstein-Barr virus-associated oncogenesis |
16 |
| Restriction of HIV-1 and other retroviruses by TRIM5 |
15 |
| Archaeal biofilm formation |
15 |
| Respiratory syncytial virus entry and how to block it |
15 |
| The evolution of Zika virus from Asia to the Americas |
15 |
| Going around in circles: virulence plasmids in enteric pathogens |
14 |
| Prokaryotic Argonaute proteins: novel genome-editing tools? |
14 |
| The bacterial cell cycle, chromosome inheritance and cell growth |
14 |
| Prisoners of war - host adaptation and its constraints on virus evolution |
13 |
| Diverse light responses of cyanobacteria mediated by phytochrome superfamily photoreceptors |
13 |
| Citrobacter rodentium-host-microbiota interactions: immunity, bioenergetics and metabolism |
13 |
| Microbial invasions in terrestrial ecosystems |
13 |
| Zika virus vaccines |
13 |
| New opportunities for managing acute and chronic lung infections |
12 |
| Sulfur metabolites in the pelagic ocean |
12 |
| Viral RNA structure-based strategies to manipulate translation |
11 |
| Microbial niches in marine oxygen minimum zones |
11 |
| CRISPR-based genomic tools for the manipulation of genetically intractable microorganisms |
11 |
| Microbial ageing and longevity |
6 |
